- $2.5 BnWorld market, 2023
- $3.6 BnProjected, 2033
- 3.8%Growth a year (CAGR)
- 16Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$1.1 Bn
1.8% a year · 42% of the world -
2
China
$201 Mn
5.3% a year · 8% of the world -
3
Canada
$200 Mn
3.8% a year · 8% of the world -
4
Japan
$155 Mn
4.3% a year · 6.2% of the world -
5
Germany
$92 Mn
2% a year · 3.7% of the world -
6
France
$69 Mn
2.8% a year · 2.8% of the world -
7
UK
$65 Mn
1.8% a year · 2.6% of the world -
8
Brazil
$63 Mn
4.8% a year · 2.5% of the world -
9
Italy
$60 Mn
3.3% a year · 2.4% of the world -
10
Ecuador
$50 Mn
4.4% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Egypt
New ZealandOver The Counter (OTC) Antifungal by country and region
Spain
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 2,953 papers since 2021
- Kerion-like scalp disease in a child with a culture isolate reported as Aspergillus lentulus. Medical mycology case reports, 2026
- Molecularly confirmed neoscytalidium dimidiatum onychomycosis in an immunocompetent Iranian woman: a case report and comprehensive literature review. IDCases, 2026
- Adaptive responses to antifungal selection depend on dose and drug combination in experimentally evolved yeast. bioRxiv : the preprint server for biology, 2026
- Terbinafine-Resistant Tinea Corporis Caused by Trichophyton indotineae in a Nepalese Hotel Worker in Japan. The Journal of dermatology, 2026
- Mixed infection of Microsporum, Candida, and Malassezia spp. in a Persian cat: A unique case in Rohilkhand region of Uttar Pradesh, India. Iranian journal of veterinary research, 2026
Compare Over The Counter (OTC) Antifungal side by side
Quick answers
How big is the Over The Counter (OTC) Antifungal market?
The world Over The Counter (OTC) Antifungal market was worth about $2.5 Bn in 2023 and is projected to reach $3.6 Bn by 2033, growing 3.8% a year (CAGR).
Which country has the largest Over The Counter (OTC) Antifungal market?
The US is the largest of the 24 countries we cover, at $1.1 Bn in 2023. India grows fastest, at 6.8% a year.
How many clinical trials are running in Over The Counter (OTC) Antifungal?
ClinicalTrials.gov lists 16 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Over The Counter (OTC) Antifungal?
PubMed lists about 2,953 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.